Related Experiment Videos
Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions
T Kuhlmann1, C Lucchinetti, U K Zettl
1Department of Neuropathology, University of Göttingen, Göttingen, Germany.
Glia
|September 28, 1999
Summary
In multiple sclerosis (MS), bcl-2 expression correlates with oligodendrocyte preservation and remyelination in lesions. This suggests apoptosis-associated proteins may influence oligodendrocyte survival during MS progression.
Area of Science:
- Neuroimmunology
- Cell Biology
Background:
- Multiple sclerosis (MS) is a central nervous system inflammatory disease causing myelin and oligodendrocyte damage.
- The precise mechanisms of myelin destruction and immune targets in MS remain unclear.
- Oligodendrocyte survival in active MS lesions is variable and patient-dependent.
Purpose of the Study:
- To investigate the association between bcl-2 expression and oligodendrocyte preservation in early MS lesions.
- To determine if bcl-2, an anti-apoptotic protein, influences oligodendrocyte survival in MS.
Main Methods:
- Double immunocytochemistry using antibodies for bcl-2 and myelin oligodendrocyte glycoprotein (MOG).
- Analysis of bcl-2-expressing oligodendrocytes in MS lesions from 43 patients.
- Correlation of oligodendrocyte counts with lesion demyelination activity and disease course.
Main Results:
- Increased bcl-2-positive oligodendrocytes were found in demyelinating lesions compared to periplaque white matter.
- Highest numbers of bcl-2-expressing oligodendrocytes were observed in remyelinating lesions.
- A significant association exists between bcl-2-positive oligodendrocytes and remyelination, particularly in relapsing-remitting MS patients.
Conclusions:
- Oligodendrocyte preservation in MS lesions is linked to bcl-2 expression.
- Apoptosis-associated proteins like bcl-2 may play a role in oligodendrocyte survival or loss in MS.
- Findings suggest potential therapeutic targets for promoting oligodendrocyte survival in multiple sclerosis.